日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The T385M STAT1 gain-of-function mutation confers the most severe disease outcomes

T385M STAT1 功能获得性突变会导致最严重的疾病后果。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1717692
Torrance, Robert; McKenna, Alexander J; King, Catherine; McDowell, Joe; O'Callaghan, Eleanor; Maimaris, Jesmeen; Albuquerque, Adriana S; Pearce, Rachel; Morris, Emma C; Burns, Siobhan O
JAK/STAT
STAT1
发表日期：2025
文献求助 收藏

Correction to: Inherited CD19 Deficiency Does Not Impair Plasma Cell Formation or Response to CXCL12

更正：遗传性 CD19 缺陷不会损害浆细胞的形成或对 CXCL12 的反应

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-025-01889-9
Walker, Kieran; Mistry, Anoop; Watson, Christopher M; Nadat, Fatima; O'Callaghan, Eleanor; Care, Matthew; Crinnion, Laura A; Arumugakani, Gururaj; Bonthron, David T; Carter, Clive; Doody, Gina M; Savic, Sinisa
CXCL1
CXCL12
细胞生物学
CD19
发表日期：2025
文献求助 收藏

Enforced MYC expression directs a distinct transcriptional state during plasma cell differentiation.

MYC 的强制表达在浆细胞分化过程中指导着一种独特的转录状态

期刊:Life Science Alliance
影响因子:2.9
doi:10.26508/lsa.202402814
Vardaka Panagiota, Kemp Ben, Stephenson Sophie, Page Eden, Care Matthew A, Umpierrez Michelle, Annahar Adam, O'Callaghan Eleanor, Owen Roger, Hodson Daniel J, Doody Gina M, Tooze Reuben M
细胞生物学
发表日期：2025
文献求助 收藏

Inherited CD19 Deficiency Does Not Impair Plasma Cell Formation or Response to CXCL12

遗传性 CD19 缺陷不影响浆细胞的形成或对 CXCL12 的反应

期刊:Journal of Clinical Immunology
影响因子:5.7
doi:10.1007/s10875-023-01511-w
Walker, Kieran; Mistry, Anoop; Watson, Christopher M; Nadat, Fatima; O'Callaghan, Eleanor; Care, Matthew; Crinnion, Laura A; Arumugakani, Gururaj; Bonthron, David T; Carter, Clive; Doody, Gina M; Savic, Sinisa
CXCL1
CXCL12
细胞生物学
CD19
发表日期：2023
文献求助 收藏